Home/ARTHEx Biotech/Pedro Fernández, PhD
PF

Pedro Fernández, PhD

Director of Operations

ARTHEx Biotech

ARTHEx Biotech Pipeline

DrugIndicationPhase
ATX-01 (ArthemiR trial)Myotonic Dystrophy Type 1 (DM1)Phase 1/2